Institut Paoli Calmettes Myelodysplastic Syndromes Database

Recruiting

• Conditions: Myelodysplastic Syndromes

• Registration Number: NCT03275480
• Lead Sponsor: Institut Paoli-Calmettes

Brief Summary

Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes

Detailed Description

Not available

Study Timeline

• Study Start: 2016-01-18
• Study First Submitted: 2017-09-06
• Study First Submitted QC: 2017-09-06
• Study First Posted: 2017-09-07
• Status Verified: 2019-05
• Last Update Submitted: 2019-05-13
• Last Update Posted: 2019-05-14
• Primary Completion: 2030-01
• Study Completion: 2030-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10000

Inclusion Criteria

• Patient with a diagnosis of Myelodysplastic Syndromes

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival of patients with myelodysplastic syndrome(MDS)	10 years	Overall survival of all patients with MDS who are taken in charge in Institut Paoli Calmettes Cancer Center

Secondary Outcome Measures

Name	Time	Method
Collection of patients characteristics	10 years	Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies

Trial Locations

Locations (1)

Institut Paoli-Calmettes; 🇫🇷 Marseille, Paca, France